Administration of probiotics to healthy volunteers: effects on reactivity of intestinal mucosa and systemic leukocytes

Abstract

Background Oral administration of health-promoting bacteria is increasingly used in clinical practise. These bacteria have anti-inflammatory characteristics and modulate the immune system without major reported side effects. The mechanisms of action are not yet fully defined. Our aim was to study systemic effects of probiotics by measurements of leukocytes as well as local effects on rectal mucosal biopsies after adding a standardized inflammatory stimulus in vitro. Methods Fourteen healthy subjects were randomized to receive 1010 colony forming units/day orally of the probiotic strain Lactiplantibacillus plantarum 299 (Lp299), n = 7, or Bifidobacterium infantis CURE21 (CURE21), n = 7, for six weeks. Rectal biopsies were taken before and after ingestion of either probiotic strain product, for stimulation in vitro with tumour necrosis factor alpha (TNF-α) at 10 and 100 ng/ml respectively up to 8 h. Blood tests were sampled before and after treatment. Lactate dehydrogenase (LDH) confirmed viable tissue. Results Composition of the intestinal microbiota was not changed. Systemic leukocytes decreased after administration of CURE21 (P<0.05) and Lp299 (P<0.01). Levels of the pro-inflammatory cytokine IL-6 in rectal mucosa after stimulation with TNF-α were attenuated after ingestion of Lp299. No effect was seen with CURE21. Conclusions Administration of these probiotic strains to healthy humans show both a systemic and local reduction of inflammatory response by lowering leukocyte counts, and for Lp299 IL-6 levels in rectal mucosa. Probiotics may play an important role in the reduction of inflammatory responses expected after trauma during surgery or after pelvic irradiation. Trial registration Clinical Trials, registration number NCT01534572, retrospectively registered (http://www.clinicaltrials.gov).

Exploring the In Vitro Antibacterial Potential of Specific Probiotic Strains against Oral Pathogens

“…Several clinical trials reported improvement in halitosis, oral health, and related quality of life in subjects supplemented with different formulation of probiotics [ 65 , 66 , 67 , 68 , 69 ]. Moreover, many beneficial effects have been already demonstrated in the rebalance of the gut microbiota and also systemically [ 70 , 71 , 72 ]. Diverse Lactobacillus species exhibit immunomodulatory activities in the host gut, including enhanced antioxidant status and production of adhesion molecules and prevention of the establishment of neutrophil extracellular traps [ 73 , 74 ].…”

Effects of three different probiotics of Tibetan sheep origin and their complex probiotics on intestinal damage, immunity, and immune signaling pathways of mice infected with Clostridium perfringens type C

“…In a healthy population, the use of probiotics can reduce systemic inflammatory responses ( Wang et al, 2022 ). In broilers infected with C. perfringens , the addition of Bacillus subtilis was effective in improving necrotizing intestinal lesions and regulating intestinal health ( Li et al, 2017 ; Stene et al, 2022 ). Lactobacillus casei was effective in suppressing Salmonella induced intestinal inflammation in chicks and improving intestinal mucosal immunity ( Cheng et al, 2018 ).…”

A Review of Immunomodulatory Reprogramming by Probiotics in Combating Chronic and Acute Diabetic Foot Ulcers (DFUs)

“…This significant decrease in inflammation was accompanied by a 50% decrease in the WBC count in the wound area [157]. Another study conducted on healthy individuals who were supplemented with Lactobacillus and Bifidobacterium probiotics for 6 weeks showed a decreased production of leukocytes (WBCs) and proinflammatory cytokines (IL-6 and TNF-α), showing the important role of probiotics in maintaining healthy intestinal homeostasis [158].…”